EMA Recommends Avoidance of Some Hepatitis C Drugs With Amiodarone
April 24 2015 - 7:46AM
Dow Jones News
LONDON-- The European Medicines Agency Friday confirmed a risk
of slow heart rate or problems with conduction of electrical
signals in the heart when the hepatitis C medicines Harvoni,
produced by Gilead Sciences Inc. (GILD), or a combination of
Gilead's Sovaldi and Bristol-Myers Squibb Co's (BMY) Daklinza are
used in patients who are also taking the medicine amiodarone.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter:
@RoryGallivan
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024